baber/WOPTO huggingface dataset:
Patent MX-PA03010695-A (MX)
Title: Dental hygiene device.
Inventor: DIEGO SODO
IPC: A61C17/032
Filed: 2002-05-16
Abstract: The dental hygiene device comprises means for connecting it to a water tap and means for delivering the water in a way suitable for cleaning teeth, which comprises means for adjusting the pressure of the water capable of being associated with and disassociated from the connection means to deactivate and activate, respectively, static aeration means of the water operatively associated with the connection means.
Patent MX-PA04000517-A (MX)
Title: Ascites preventives for poultry.
Inventor: MINEMURA TSUYOSHI
IPC: A61P3/00
Filed: 2002-07-17
Abstract: It is intended to provide preventives for ascites containing coenzyme Q which can exert a sufficient effect of preventing ascites even in case of administering in a small dose within a short period of time, and ascites preventives which can be effectively administered to poultry by a convenient method. Namely, ascites preventives for poultry containing coenzyme Q and a surfactant, wherein the content of the surfactant ranges from 0.5 to 80 parts by weight based on the whole preventives.
Patent MX-PA04001606-A (MX)
Title: Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander.
Inventor: KLAUS SOMMERMEYER
IPC: C08B35/00
Filed: 2002-08-06
Abstract: The invention relates to the use of hyperbranched amylopectin which has an average branch degree of between > 10 and 25 mol % and a molecular weight (Mw) ranging from 40.000 - 800.000 Dalton and the derivatives thereof in methods for surgical or therapeutic treatment of human or animal bodies or in a diagnostic method, preferably as a plasma volume expander. Plasma volume expanders based on hydroxy-ethylated amylopectin have, as a result of hydroxy ethylation, hitherto exhibited the disadvantage of incomplete metabolism and thus temporary tissue storage which is linked to side-effects. According to the invention, novel plasma expanders based on polysaccharides which do not exhibit the same disadvantages as the former are provided. Improved, completely metabolised plasma expanders based on hyperbranched amylopectin which can be obtained therefrom so that native plant-amylopectins are altered by transglycosylation in such a way the adjustable, high degree of branching enables control of the serum- alpha -amylase decomposition so that no or only a very insignificant degree of hydroxy ethylation is necessary.
Patent MX-PA04004571-A (MX)
Title: Improvements in receivers for television signals.
Inventor: BRIAN FRANCIS SULLIVAN
IPC: H04N21/458
Filed: 2002-11-13
Abstract: A television signals receiver for receives and stores television signals encoded at a variable data rate. Time information is generated based on the time of receipt of the signals that defines the duration of the television signals when output in decompressed form at a substantially constant data rate. The received signals are then written to a file on a hard disk (13) in received order together with the time information. The time information of signals stored in the file is monitored and old signals are deleted from the file such that the file stores signals corresponding to a predetermined period of time.
Patent MX-PA04005601-A (MX)
Title: Superoxide dismutase mimics for the treatment of ocular disorders and diseases.
Inventor: ROBERT J COLLIER JR
IPC: A61P27/02
Filed: 2002-12-06
Abstract: The use of SOD mimics particularly pentaazacycle Mn(II) complex SOD mimics, for the treatment of AMD, DR, and retinal edema is disclosed.
Patent MX-PA04006581-A (MX)
Title: Sulfonate derivatives and the use therof as latent acids.
Inventor: PETER MURER
IPC: C07C323/66
Filed: 2003-01-28
Abstract: Chemically amplified photoresist compositions comprising, (a) a compound which cures upon the action of an acid or a compound whose solubility is increased upon the action of an acid; and (b) a compound of the formula (Ia), (Ib), (IIa), (IIb), (IIIa), (IIIb), (Iva), (Ivb), (Va), (Vb) or (VIa), wherein n is 1 or 2; m is 0 or 1; X0 is -[CH2]h-X or -CH=CH2; h is 2, 3, 4, 5 or 6; R1 when n is 1, is for example optionally substituted phenyl, naphthyl, anthracyl, phenanthryl, or heteroaryl; R1, when n is 2, is for example optionally substituted phenylene or naphthylene; R2 for example has one of the meanings of R1; X is for example -OR20, -NR21R22, -SR23; X' is -X1-A3-X2-; X1 and X2 are for example -O-, -S- or a direct bond; A3 is e.g. phenylene; R3 has for example one of the meanings given for R1; R4 has for example one of the meaning given for R2; R5 and R6 e.g. are hydrogen; G i.a. is -S- or -O-; R7 when n is 1, e.g. is phenyl, optionally substituted, when n is 2, is for ex -ample phenylene; R8 and R9 e.g. are C1-C18alkyl; R10 has one of the meanings given for R7; R11 i.a. is C1-C18alkyl; R12, R13, R14, R15 R16, R17 and R18 for example are hydrogen or C1- -C18alkyl; R20, R21, R22 and R23 i.a. are phenyl or C1-C18alkyl; give high resolution with good resist profile.
Patent MX-PA04008302-A (MX)
Title: Process for producing l-threonine with the use of bacterium beloniging to the genus escherichia.
Inventor: KOZLOV YURI IVANOVICH
IPC: C12N1/21
Filed: 2003-02-25
Abstract: L-Threonine is produced by using an L-threonine-producing bacterium which belongs to the genus Escherichia and has been modified to enhance the asparatate aminotransferase activity.
Patent MX-PA04012711-A (MX)
Title: Novel compounds, their use and preparation.
Inventor: SJOEBERG BIRGER
IPC: A61P29/02
Filed: 2003-06-18
Abstract: The invention relates to compounds of the general Formula (I). The compounds may be prepared by per se conventional methods and can be used for treating a human or animal subject suffering from a serotonin-related disorder. The invention also relates to such use as well as to pharmaceutical compositions comprising a compound of Formula (I).
Patent MX-PA04012983-A (MX)
Title: Protein glycosylation modification in pichia pastoris.
Inventor: VERVECKEN WOUTER
IPC: C12N15/81
Filed: 2003-06-25
Abstract: The present invention provides genetically engineered strains of methylotrophic yeast including Pichia and especially Pichia pastoris capable of producing proteins with reduced or modified glycosylation. Methods of producing glycoproteins with reduced and/or modified glycosylation using such genetically engineered strains of Pichia are also provided. Vectors, which comprise coding sequences for alpha-1,2-mannosidase I, glucosidase II, GlcNAc-tranferase I and mannosidase II or comprising OCH1 disrupting sequence, for transforming methylotrophic yeasts are contemplated by the present invention. Kit for providing the contemplated vectors are also included in this invention.
Patent MX-PA05001449-A (MX)
Title: Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer's disease.
Inventor: ROBERTSON DAVID W
IPC: A61K31/4709
Filed: 2003-08-04
Abstract: The present invention provides compositions and methods for the treatment or prevention of Alzheimer's disease. More particularly, the invention provides a combination therapy for the treatment or prevention of Alzheimer's disease, wherein the therapy comprises administering to a subject an amyloid beta vaccine in combination with a cyclooxygenase-2 selective inhibitor.
Patent MX-PA05002338-A (MX)
Title: Preparation of partially hydrogenated rac-ansa-metallocene complexes.
Inventor: LELONG JEAN-FRANCOIS
IPC: C07B53/00
Filed: 2003-10-22
Abstract: The invention relates to a process for preparing hydrogenated or partially hydrogenated, racemic ansa-metallocene complexes by reacting bridged or unbridged transition metal complexes with alkali metal compounds or alkaline earth metal compounds, heating the resulting reaction mixture to a temperature in the range from -78 to 250¦C and at least partially hydrogenating the reaction products in the presence of a suitable catalyst, to the corresponding hydrogenated or partially hydrogenated metallocenes and to their use as catalysts or as a constituent of catalysts for the polymerization of olefinically unsaturated compounds or as reagents or catalysts in stereoselective synthesis.
Patent MX-PA05003039-A (MX)
Title: Solid pharmaceutical formulations comprising telmisartan.
Inventor: SAWADA TAKESHI
IPC: A61K9/20
Filed: 2003-09-18
Abstract: The invention relates to new solid pharmaceutical compositions comprising the angiotensin II receptor antagonist telmisartan, a basic agent, a surfactant or emulsifier and a water-soluble diluent, e.g. in form of granules or in form of a powder, as well as solid oral formulations ready for use/ingestion, e.g. capsule and tablet formulations made from said pharmaceutical compositions, and methods for producing said compositions and formulations making use of a fluid-bed granulation process or of a spray-drying process.
Patent MX-PA05008591-A (MX)
Title: Silo for dispensing bulk products.
Inventor: VALLE JAIR
IPC: B65D83/06
Filed: 2005-08-12
Abstract: The present invention refers to a silo for dispensing bulk products. In a first embodiment, the silo is hinged so that it can be tilted for facilitating the bulk product refill. Said silo further comprises an self-cleaned aperture which prevents said bulk product from being accumulated into said silo.
Patent MX-PA05009059-A (MX)
Title: Heteroarylcarbamoylbenzene derivative.
Inventor: TAKAHASHI KEIJI
IPC: C07D231/40
Filed: 2004-02-26
Abstract: A compound represented by the following formula (I): (I) [wherein X1 represents oxygen, etc.; X2 represents oxygen, etc.; R1 represents an alkylsulfonyl or another group on the ring A; R2 represents, e.g., C3-7 cyclic alkyl optionally substituted by halogeno, etc.; R3 represents a substituent on the ring B, e.g., lower alkyl; the formula (II) [Chemical formula 1] (II) represents 6- to 10-membered aryl, etc.; and the formula (III) [Chemical formula 1] (III) represents a mono- or bicyclic heteroaryl which optionally has a substituent represented by the R3 in the ring B and in which the carbon atom bonded to the nitrogen atom of the amide group in the formula (I) forms C=N in cooperation with the nitrogen atom of the ring] or a pharmaceutically acceptable salt of the compound. The compound and salt function to activate glucokinase and are useful as a therapeutic agent for diabetes.
Patent MX-PA05009352-A (MX)
Title: Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections.
Inventor: BALABAN NAOMI
IPC: A61K38/08
Filed: 2004-01-30
Abstract: The invention features methods and compositions for treatment or prevention of infection by, or disease caused by infection with, certain species of bacteria, including in particular bacteria in which a RAP-type and/or TRAP-type molecule plays a role in pathogenesis. This includes Staphylococcus species.
Patent MX-PA06000794-A (MX)
Title: 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators.
Inventor: WYATT PAUL GRAHAM
IPC: C07D403/12
Filed: 2004-07-22
Abstract: The invention provides compounds of the formula (0) or salts or tautomers or N-oxides or solvates thereof for use in the prophylaxis or treatment of disease states and conditions such as cancers mediated by cyclin-dependent kinase and glycogen synthase kinase-3. Formula (0). In formula (0): X is a group R1-A-NR4- or a 5- or 6-membered carbocyclic or heterocyclic ring; A is a bond, S02, C=O, NRg(C=O) or O(C=O) wherein Rg is hydrogen or C1-4 hydrocarbyl optionally substituted by hydroxy or C1-4 alkoxy; Y is a bond or an alkylene chain of 1, 2 or 3 carbon atoms in length; R1 is hydrogen; a carbocyclic or heterocyclic group having from 3 to 12 ring members; or a C1-8 hydrocarbyl group optionally substituted by one or more substituents selected from halogen (e.g. fluorine), hydroxy, C1-4 hydrocarbyloxy, amino, mono- or di-C1-4 hydrocarbylamino, and carbocyclic or heterocyclic groups having from 3 to 12 ring members, and wherein 1 or 2 of the carbon atoms of the hydrocarbyl group may optionally be replaced by an atom or group selected from 0, S, NH, SO, S02; R2 is hydrogen; halogen; C1-4 alkoxy (e.g. methoxy); or a C1-4 hydrocarbyl group optionally substituted by halogen (e.g. fluorine), hydroxyl or C1-4 alkoxy (e.g. methoxy); R3 is selected from hydrogen and carbocyclic and heterocyclic groups having from 3 to 12 ring members; and R4 is hydrogen or a C1-4 hydrocarbyl group optionally substituted by halogen (e.g. fluorine), hydroxyl or C1-4 alkoxy (e.g. methoxy).
Patent MX-PA06003664-A (MX)
Title: Systems and devices for delivering volatile materials.
Inventor: FARRELL MICHAEL SEAN
IPC: A61L9/04
Filed: 2004-10-01
Abstract: A non-energized volatile material delivery system for emitting or releasing volatile materials to the atmosphere is provided. More specifically, delivery systems for delivering one or more volatile materials using a non-aerosol, non-energized volatile material delivery system via an evaporative surface device, without a source of heat, gas, or electrical current, are also provided.
Patent MX-PA06003803-A (MX)
Title: P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same.
Inventor: KIM MAENG SUP
IPC: C07D405/12
Filed: 2004-10-06
Abstract: The bioavailability of an anticancer agent is enhanced when the anticancer agent is administered together with a pharmaceutical composition comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof.
Patent MX-PA06011338-A (MX)
Title: Refrigeration appliance.
Inventor: HEINZLE MARCOS
IPC: F25D17/00
Filed: 2005-04-01
Abstract: a cabinet (10) defining a refrigerating compartment (RC) and an air refrigerating chamber (15) housing at least one evaporator (20) and at least one fan (30); and at least one freezing compartment (FC) provided with a respective front door (61) and which is optionally and selectively mounted inside the cabinet (10), so as to occupy at least a portion of the inner volume of the latter and to be maintained in fluid communication with the air refrigerating chamber (15) through at least one outlet opening (52) of a freezing air supply duct (50) and through at least one inlet window (91) of a freezing air return duct (90), said refrigerating compartment (RC) being maintained in fluid communication with the air refrigerating chamber (15) through a refrigerating air supply duct (40) and a refrigerating air return duct (80).
Patent MX-PA06011925-A (MX)
Title: Stepped tendon with sealed bulkheads for offshore platform.
Inventor: HUANG EDWARD
IPC: E02D23/00
Filed: 2005-04-13
Abstract: A tension leg platform is secured to the sea floor with a plurality of tendons, each of the tendons being in tension due to buoyancy of the platform. The tendons are made up of joints of pipe secured together to define a hollow interior sealed from entry of sea water. A lower section of the joints of pipe of each of the tendons has smaller inner and outer diameters and greater wall thicknesses than an upper section of the joints of pipe. Bulkheads are sealed within the interior of the upper and lower sections of the joints of pipe of each of the tendons. The bulkheads are spaced apart from each other along the lengths of the upper and lower sections of the joints of pipe to defined separate compartments sealed from each other.
Patent MX-PA06012899-A (MX)
Title: Antimicrobial articles.
Inventor: LUCAST DONALD H
IPC: A61F13/00
Filed: 2005-05-06
Abstract: An antimicrobial article is disclosed comprising a layer of a thermoplastic polymer, and an adhesive layer having a antimicrobial agent dispersed therein. The antimicrobial article is useful, for example, surgical tapes, surgical drapes and wound dressings, and as disposable surfaces for food preparation and handling.
Patent MX-PA06013858-A (MX)
Title: Methods and systems for measuring cardiac parameters.
Inventor: BOTTCHER ROBERT
IPC: A61C8/00
Filed: 2004-08-18
Abstract: Methods and systems of the present invention provide for measurement of various cardiac parameters. Methods generally involve causing a change in volume and/or pressure in a heart chamber, measuring the change, and calculating at least one cardiac parameter based on the change. Systems typically include at least one actuator, at least one sensor, and a catheter or other device for positioning at least partially in a heart chamber. In some embodiments, the system may also include a controller, such as a computer or other processor, an external actuator, an external sensor, and/or an ECG device. Methods and systems of the invention may be used to more accurately diagnose cardiac conditions in order to make more informed treatment decisions.
Patent MX-PA06014847-A (MX)
Title: Antimicrobial insulation.
Inventor: SWOFFORD HOWARD WAYNE
IPC: B32B27/00
Filed: 2005-05-04
Abstract: Insulation that exhibits antimicrobial characteristics is disclosed. A method for making the insulation is also disclosed. Suitable antimicrobial agents that may be applied to the insulation or any components thereof include propiconazole, sodium pyrithione, tolyl diiodomethyl sulfone; tebuconazole; thiabendazole; 3-iodo-2 ipropynyl butylcarbamate; triclosan, quaternary ammonium compounds, metals, and mixtures thereof.
Patent MY-104920-A (MY)
Title: Peptide boronic acid inhibitors of trypsin-like proteases.
Inventor: ASHOKKUMAR BHIKKAPPA SHENVE
IPC: C07F5/00
Filed: 1988-06-04
Abstract: PEPTIDES COMPRISING C-TERMINAL BORONIC ACID DERIVATIVES OF LYSINE, ORNITHINE, AND ARGININE, HOMOARGININE AND CORRESPONDING ISOTHIOURONIUM ANALOGS THEREOF, ARE REVERSIBLE INHIBITORS OF TRYPSIN-LIKE SERINE PROTEASES SUCH AS THROMBIN, PLASMA KALLIKREIN AND PLASMIN.
Patent MY-106432-A (MY)
Title: Uniaxial plug
Inventor: HIROICHI MATSUMOTO
Filed: 1990-07-26
Abstract: A UNIAXIAL PLUG SERVES AS A UNIAXIAL CONNECTOR TO BE INSERTED INTO A JACK AND THE LIKE. THE UNIAXIAL PLUG HAS A PLUG BODY TO BE INSERTED INTO THE JACK AND THE LIKE AND A CODE SUPPORTING MEMBER MOUNTED ON THE BASE OF THE PLUG BODY AND PROVIDED WITH THE HELICAL GROOVE AND THE CODE HOLDING PORTION. A CODE IS CONNECTED TO THE REAR END OF THE PLUG BODY IN THE CODE SUPPORTING MEMBER AND THE SAME CODE IS WOUND IN THE HELICAL GROOVE AND HELD BY THE CODE HOLDING PORTION. IF THE CODE SUPPORTING MEMBER IS SUBSTANTIALLY ENTIRELY COVERED BY A DETACHABLE COVER, THE UNIAXIAL PLUG CAN BE STRUCTURED AND ASSEMBLED WITH EASE THEREBY MINUTUARIZING THE SIZE AND IMPROVING THE ELECTRICAL AND MECHANICAL INTENSITY.(FIG 3)
Patent MY-108432-A (MY)
Title: Slider with yoke for slide fastener and its joining method.
Inventor: HIROSHI YOSHIDA
IPC: A44B19/26
Filed: 1992-04-27
Abstract: A NOVEL AND IMPROVED SLIDER WITH A YOKE FOR A SLIDE FASTENER AND A NOVEL AND IMPROVED METHOD FOR ATTACHING OR JOINING THE YOKE TO THE SLIDER BODY, WHICH MAY BE CARRIED OUT IN SIMPLE OPERATION TO BE ATTRACTIVE IN APPEARANCE AND TO PROVIDE FIRM COMBINATION BETWEEN THE YOKE AND THE SLIDER BODY.THE FRONT AND REAR SUPPORT POSTS THE SLIDER BODY ARE RESPECTIVELY PROVIDED WITH LOCKING GROOVE AND THE CONTACT FACES OF THE YOKE ARE ALSO PROVIDED WITH BULGED PORTIONS OPPOSITE TO THE LOCKING GROOVES. IN A PREFFERRED EMBODIMENT, AFTER THE SUPPORT POSTS ARE COVERED WITH THE YOKE, A PRESS FORCE IS APPLIED TO THE BULGED PORTION IN THE FORGING PROCESS TO FLOW THE MATERIAL OF THE BULGED PORTION INTO THE LOCKING GROOVE SO AS TO PROVIDE THE FIRM COMBINATION.IN THE OTHER PREFERRED EMBODIMENT, AFTER THE YOKE IS COVERED ON THE SUPPORT POSTS AND IS PRESSED IN THE DEEPLY COVERING DIRECTION, A PART OF EACH SUPPORT POST IS DEFORMED BY PLASTIC FLOW TO FORM A BULGED PORTION IN THE LOCKING GROOVE OF THE YOKE SO AS TO COMBINE THE YOKE WITH THE SUPPORT POSTS. (FIG 1)
Patent MY-109509-A (MY)
Title: Well logging method and apparatus using annular and azimuthal electrodes
Inventor: BRONISLAW SEEMAN
IPC: G01V3/24
Filed: 1992-11-09
Abstract: THE INVENTION RELATES TO AN ELECTRICAL LOGGING METHOD AND APPARATUS USING ELECTRODES. THE APPARATUS COMPRISES AN ANNULAR CURRENT ELECTRODE (AO) MOUNTED ON A BODY AND GUARD ELECTRODES (A2, A''2) DISPOSED ON THE BODY ABOVE AND BELOW THE ANNULAR CURRENT ELECTRODE. A FIRST MEASUREMENT CURRENT (IO) IS EMITTED BY THE CENTRAL CURRENT ELECTRODE (AO) AND FOCUSING CURRENTS ARE EMITTED BY THE GUARD ELECTRODES (A2, A''2). A FIRST OUTPUT SIGNAL REPRESENTATIVE OF THE DEEP RESISTIVITY OF THE FORMATIONS IS GENERATED IN RESPONSE TO THE FIRST MEASUREMENT CURRENT (IO). ONE OF THE GUARD ELECTRODES (A2) COMPRISES TWO LONGITUDINALLY SPACED-APART PORTIONS, AND AN ARRAY OF AZIMUTHAL CURRENT ELECTRODES (AAZI) THAT ARE CIRCUMFERENTIALLY SPACED-APART FROM ONE ANOTHER IS DISPOSED BETWEEN THESE TWO PORTIONS. SECOND MEASUREMENT CURRENT (IAZI) EMITTED BY THE AZIMUTHAL CURRENT ELECTRODES (AAZI) ARE FOCUSED LONGITUDINALLY BY THE CURRENTS EMITTED BY THE SAID TWO PORTIONS OF THE GUARD ELECTRODE (A2). SECOND OUTPUT SIGNALS ARE GENERATED IN RESPONSE TO THE SECOND MEASUREMENT CURRENT (IZA), WHICH OUTPUT SIGNALS ARE REPRESENTATIVE OF THE RESISTIVITY OF THE FORMATIONS IN A PLURALITY OF DIRECTIONS AROUND THE BOREHOLE. A HIGH RESOLUTION RESISTIVITY SIGNAL IS CALCULATED AS A FUNCTION OF THE MEAN OF THE SECOND MEASUREMENT CURRENTS (IAZ).(FIG 1)
Patent MY-110726-A (MY)
Title: Fluorous multiphase systems
Inventor: JOZSEF RABAI
IPC: C07D333/76
Filed: 1994-06-20
Abstract: STOICHIOMETRIC AND CATALYST CHEMICAL TRANSFORMATIONS MAY BE CARRIED OUT IN SOLUTION USING NOVEL FLUOROUS MULTIPHASE SYSTEMS (FMS). THE TERN "FLUOROUS" IS DEFINED AS A CARBON-FLUORINE BOND RICH ORGANIC MOLECULE WHICH IS GENERATED BY REPLACING HYDROGEN ATOMS BONDED TO CARBON ATOMS WITH FLUORINE. THE FMS CONSISTS OF A FLUOROUS PHASE CONTAINING A FLUOROUS SOLVENT, TYPICALLY A FLUOROCARBON OR A FLUOROHYDROCARBON, EITHER OF THE FOREGOING WITH OR WITHOUT SUBSTITUENT GROUPS, AND A REAGENT OR A CATALYST CONTAINING A SUFFICIENT NUMBER OF FLUOROUS MOIETIES TO RENDER IT PREFERENTIALLY SOLUBLE IN THE FLUOROUS SOLVENT AND LOCATED AT THE INTERFACE OF THE FLUOROUS AND NONFLUOROUS PHASES. THE NONFLUOROUS I.E. THE SECOND SOLVENT, MAY BE ANY KNOWN ORGANIC OR NONORGANIC SOLVENT(S) WITH LIMITED OR NO SOLUBILITY IN THE FLUOROUS SOLVENT THAT IS EFFECTIVE FOR DISSOLVING THE REACTANTS AND/OR SEPARATING THE REACTION PRODUCTS. TYPICALLY A NONFLUOROUS SOLVENT HAVING A HILDEBRAND SOLUBILITY PARAMETER OF AT LEAST ABOUT 18.0 MPA1/2 IS SUITABLE. THE REACTION CAN OCCUR SIMULTANEOUSLY IN THE FLUOROUS PHASE AND AT THE INTERFACE OF THE PHASES. THE FMS REAGENTS AND FMS CATALYST IN THE PRESENT INVENTION CONTAIN SIFFICIENT NUMBER OF FLUOROUS MOIETIES TO RENDER THEM PREFERENTIALLY SOLUBLE INTO THE FLUOROUS PHASE AND AT THE INTERFACE WITHOUT IMPAIRING THE ABILITY OF THE CATALYST OR REAGENT TO BE EFFECTIVE OR PARTICIPATE IN THE REACTION AND WHILE MAINTAINING THE REACTION IN A LIQUID OR FLUID PHASE. THE MOST APPROPRIATE FLUOROUS MOIETIES ARE LINEAR, BRANCHED AND CARBOCYLIC FLUOROCARBON ALKYL CHAINS WITH HIGH CARBON NUMBERS THAT ARE EFFECTIVE TO ENABLE THE CATALYST OR REAGENT TO REMAIN FLUOROUS PHASE COMPATIBLE. THE FLUOROUS MOIETIES, OPTIONALLY, MAY ALSO CONTAIN O,S, N, P, AS AND SI, THAT ASSIST IN RENDERING THE CATALYSTS AND REAGENTS FLUOROUS PHASE COMPATIBLE. THE FMS REAGENTS AND CATALYST CAN BE PREPARED BY (1) FLUORINATION (I.E., REPLACEMENT OF C-H BONDS WITH FLUORINE); (2) FLUOROFUNCTIONALIZATION, E.G.,THE ATTACHMENT OF FLUOROUS MOIETIES TO THE REAGENTS OR CATALYST; OR (3) BY TOTAL SYNTHESIS.THE FLUOROUS MULTIPHASE SYSTEMS HAVE UTILITY FOR FACILITATING THE SEPARATION OF THE FMS CATALSYT OR SPENT FMSREAGENT. THE POSSIBILITY OF SEPARATING THE CATALYST OR THE SPENT REAGENT FROM THE PRODUCTS HAS UTILITY IN THE DESIGN AND SYNTHESIS OF CATALYST AND REAGENTS WITH HIGH PRODUCT SELECTIVITY, RESULTING INESPECIALLY ENVIRONMENTALLY FRIENDLY PROCESSES.